tiprankstipranks
Forte Biosciences Inc. (FBRX)
:FBRX
US Market

Forte Biosciences (FBRX) Income Statement

Compare
304 Followers

Forte Biosciences Income Statement

Last quarter (Q3 2024), Forte Biosciences's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Forte Biosciences's net income was $-8.39M. See Forte Biosciences’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ -9.00K$ 0.00$ -36.00K$ -54.00K$ -11.00K
Operating Expenses
$ 32.48M$ 13.90M$ 21.49M$ 14.22M$ 4.06M
Depreciation and Amortization
$ 9.00K$ 36.00K$ 36.00K$ 54.00K$ 11.00K
EBITDA
$ -32.48M$ -13.90M$ -21.45M$ -46.43M$ -4.05M
Operating Income
$ -32.49M$ -13.90M$ -21.49M$ 17.83M$ -4.06M
Other Income/Expenses
$ 1.01M$ 17.00K$ -222.00K$ -205.00K$ -5.00K
Pretax Income
$ -31.48M$ -13.88M$ -21.71M$ -46.49M$ -4.07M
Net Income
$ -31.48M$ -13.86M$ -21.71M$ -78.54M$ -4.07M
Per Share Metrics
Basic EPS
$ -24.92$ -19.96$ -38.85$ -157.93$ -48.25
Diluted EPS
$ -24.92$ -19.96$ -38.85$ -157.93$ -48.25
Weighted Average Shares Outstanding
1.26M 695.34K 558.71K 294.36K 84.33K
Weighted Average Shares Outstanding (Diluted)
1.26M 695.34K 558.71K 294.36K 84.33K
Currency in USD

Forte Biosciences Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis